India vs Landlocked developing countries (LLDCs): Percentage of bloodstream infection due to methicillin-resistant
India
54.9%
in 2022
Landlocked developing countries (LLDCs)
53.8%
in 2022
India rank
6th
Landlocked developing countries (LLDCs) rank
3rd
Percentage of bloodstream infection due to methicillin-resistant over time
- India
- Landlocked developing countries (LLDCs)
How they compare
India currently reports 54.9% against 53.8% in Landlocked developing countries (LLDCs), a difference of 1.1%.
The two have swapped places 2 times across 6 shared years of data; in 2017 it was India ahead.
India ranks 6th and Landlocked developing countries (LLDCs) ranks 3rd of 44 countries.
Across the 2 decades both report, India averaged higher in 1 and Landlocked developing countries (LLDCs) in 1.
Head to head by decade
| Decade | India | Landlocked developing countries (LLDCs) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.7% | 17.2% | 41.6% | India |
| 2020s | 58.4% | 62.2% | 3.9% | Landlocked developing countries (LLDCs) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, India or Landlocked developing countries (LLDCs)?
- India, at 54.9% against 53.8% in Landlocked developing countries (LLDCs) as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between India and Landlocked developing countries (LLDCs)?
- 1.1%, with India ahead.
- How many years of comparable data are there for India and Landlocked developing countries (LLDCs)?
- 6 years are reported by both, from 2017 to 2022.
- How do India and Landlocked developing countries (LLDCs) rank globally for percentage of bloodstream infection due to methicillin-resistant?
- India ranks 6th and Landlocked developing countries (LLDCs) ranks 3rd of 44 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.